Maternal Serum Screening Markers and Adverse Outcome: A New Perspective

There have been a number of studies evaluating the association of aneuploidy serum markers with adverse pregnancy outcome. More recently, the development of potential treatments for these adverse outcomes as well as the introduction of cell-free fetal DNA (cffDNA) screening for aneuploidy necessitat...

Descripción completa

Detalles Bibliográficos
Autores principales: Krantz, David, Hallahan, Terrence, Janik, David, Carmichael, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449652/
https://www.ncbi.nlm.nih.gov/pubmed/26237472
http://dx.doi.org/10.3390/jcm3030693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449652/
https://www.ncbi.nlm.nih.gov/pubmed/26237472
http://dx.doi.org/10.3390/jcm3030693

Ejemplares similares